Correlation Between Oramed Pharmaceuticals and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Oramed Pharmaceuticals and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oramed Pharmaceuticals and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oramed Pharmaceuticals and Protalix Biotherapeutics, you can compare the effects of market volatilities on Oramed Pharmaceuticals and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oramed Pharmaceuticals with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oramed Pharmaceuticals and Protalix Biotherapeutics.
Diversification Opportunities for Oramed Pharmaceuticals and Protalix Biotherapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Oramed and Protalix is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Oramed Pharmaceuticals and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Oramed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oramed Pharmaceuticals are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Oramed Pharmaceuticals i.e., Oramed Pharmaceuticals and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Oramed Pharmaceuticals and Protalix Biotherapeutics
Given the investment horizon of 90 days Oramed Pharmaceuticals is expected to under-perform the Protalix Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Oramed Pharmaceuticals is 1.59 times less risky than Protalix Biotherapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Protalix Biotherapeutics is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest 167.00 in Protalix Biotherapeutics on November 1, 2024 and sell it today you would earn a total of 71.00 from holding Protalix Biotherapeutics or generate 42.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oramed Pharmaceuticals vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Oramed Pharmaceuticals |
| Protalix Biotherapeutics |
Oramed Pharmaceuticals and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oramed Pharmaceuticals and Protalix Biotherapeutics
The main advantage of trading using opposite Oramed Pharmaceuticals and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oramed Pharmaceuticals position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Oramed Pharmaceuticals vs. Protalix Biotherapeutics | Oramed Pharmaceuticals vs. Corvus Pharmaceuticals | Oramed Pharmaceuticals vs. Aldeyra | Oramed Pharmaceuticals vs. Checkpoint Therapeutics |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |